By possessing both tumor-promoting and tumor-suppressive functions, the effects of TGF-β/Smad signaling on cancer are complex and often depend on the types and stages of cancer and the contexts of tumor cells and tumor microenvironment [16, 17]. The gene discussed is TGFB1; the disease is cancer.